a placebo-controlled , randomized , double-blind , crossover study was performed in 14 patients with chronic , resistant , ventricular arrhythmias in order to evaluate the efficacy and safety of two new antiarrhythmic agents , propafenone and aprindine .
C0003195
antiarrhythmic agents
C0033429
propafenone